Skip to main content

23andme

By Laura Lovett | 05:17 pm | January 24, 2019
Also: 23andMe gets FDA nod for direct-to-consumer test for hereditary colorectal cancer syndrome; Mobile Heartbeat announces integration with Imprivata. 
By Dave Muoio | 05:01 pm | January 17, 2019
Also: 23andMe's global privacy officer departs for global law firm; Oscar Health hires IBM Watson Health's corporate communications head.
By Laura Lovett | 04:17 pm | January 08, 2019
Users of Lark's Wellness Program and Diabetes Prevention Program will now be able to integrate a user's genetic data from 23andMe to get a more personalized experince. 
By Dave Muoio | 06:45 pm | October 31, 2018
While the test offers information on whether or not certain treatments may be effective, the regulatory agency stressed that the results should never be used in care decisions. 
By Jonah Comstock | 03:53 pm | September 11, 2018
Also: Two telemedicine companies expand their reach, a new sensor for preventing pressure ulcers.
By Dave Muoio | 03:58 pm | August 24, 2018
23andMe has emailed developers a warning that an API permitting use of anonymized customer datasets for third-party app development will be shut down in approximately two weeks, CNBC reports.
By Dave Muoio | 05:09 pm | August 01, 2018
A group of consumer genetic and personal genomic testing companies have released a set of best practices for handling consumers’ personal genetic data.
By Bernie Monegain | 03:58 pm | July 25, 2018
23andMe on Wednesday announced that GlaxoSmithKline has invested $300 million to gain exclusive access to the genetic testing startup’s DNA database.
By Laura Lovett | 06:16 pm | June 15, 2018
In the last few years consumer genomics has grown in both its offerings and legitimacy.
By Jonah Comstock | 04:10 pm | January 04, 2018
Consumer gene testing company 23andMe is launching a large online study on the relationship between genetics and weight loss behaviors.